Management of Metastatic Breast Cancer in Frail Patients
Status:
Withdrawn
Trial end date:
2000-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of gemcitabine in treating elderly women
who have metastatic breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute